Go to the profile of NanoViricides

NanoViricides

 
  • +1-203-937-6137
  • Networkers
  • United States of America
NIAID’s technology transfer office, TTIPO, is a one-stop resource for organizations interested in partnering with NIAID to access, develop, and manage the translation of research discoveries into medically beneficial products. TTIPO seeks to expand NIAID’s innovation pipeline with existing and new partners in areas such as newly emerging and re-emerging infectious diseases (e.g., dengue, Zika, Ebola, influenza, methicillin-resistant Staphylococcus aureus and HIV/AIDS), biodefense (e.g., smallpox and anthrax), and immune-mediated diseases (e.g., asthma and allergy).
Go to the profile of Albany A. Cordova Martins
Albany A. Cordova Martins

Business Development Executive, Nature Publishing Group, Springer Nature

Go to the profile of Freya Lowe
Freya Lowe

Community Manager, Dealslands.co.uk

Lowe Freya is working as a Community Manager at Dealslands.co.uk. In her leisure time, she really likes to share her views and her trips to various places.
Go to the profile of Carmen Ramirez
Carmen Ramirez

Sales Account Executive, Springer Nature

Go to the profile of Ericka Moore
Ericka Moore

Director of Sales , SOLABS

SOLABS QM is an integrated EQMS Software that helps Medical Device, Pharmaceutical, Biotechnology, Clinical Trials, and Research & Development companies improve their operational efficiency and audit response times, and maintain GxP, GCP & GMP compliance by automating Quality Operations with respect to FDA 21 CFR Part 11 and Annex 11.
Go to the profile of Jenefer Thoroughgood
Jenefer Thoroughgood

Managing Director, Thoroughly Good Consulting

For nearly 20 years, I've worked in the digital media sector, with hands-on experience in editorial, marketing, sales and R&D. I'm passionate about engaging and understanding customers to develop great content and products. Formerly Chief Product & Customer Officer at Zapnito, I'm now an advisor to the company.
From the publishers of Nature, BioPharma Dealmakers brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. With a quarterly magazine that is distributed in Nature Biotechnology and Nature Reviews Drug Discovery, BioPharma Dealmakers provides insights into dealmaking trends and profiles from companies looking to partner – showcasing their pipeline products, technologies, therapeutic focus and partnering strategies.